SlideShare a Scribd company logo
PREPARED BY,
ATHUL RAG V
IST MPHARM
DEPT OF PHARMACY PRACTICE
JDT ISLAM COLLEGE OF PHARMACY
CASE
 A 78 YEAR OLD MALE WAS ADMITTED IN
HOSPITAL PRESENTING WITH COMPLIANTS OF
FEVER(LOW GRADE) , COUGH AND MENTAL
CONFUSION OF 1 DAY.
IP NO.IQ2015/2676
DEPT; MEDICINE
DOA;14/2/2015
DOD;16/2/2015
HISTORY
PAST MEDICAL HISTORY
 HISTORY OF BPH SURGERY UNDERGONE 2
YEARS BACK.
 HISTORY OF COPD
 NO HISTORY OF HTN,DM
PAST MEDICATION
HISTORY
 TIOMIST MDI OD
 FORACORT 400 BD
PRESENT MEDICAL
HISTORY
 HISTORY OF FEVER , COUGH, AND MENTAL
CONFUSION
ON EXAMINATION….
 Conscious and Oriented
PHYSICAL EXAMINATION
 TEMPERATURE
DAY 1
TEMP; 99⁰F
DAY 2
TEMP;98.6⁰F
 BLOOD PRESSURE
DAY 1
BP ; 100/70
DAY 2
BP ; 120/80
RESPIRATION SYSTEM
RESP.SYSTEM VALUES NORMAL
RESPIRATION RATE 30BPM 12 TO 24BPM
LAB DIAGNOSIS
 HAEMATOLOGY
VALUES NORMAL
HB 12.7g/dl 12- 16g/dl
WBC 9,500Cells/cmm 4,300 -
10,800cells/cmm
neutrophils 75 45 - 70
Platelet count 3cells/cmm 1- 4 lakhcells/cumm
monocyte 02 1 - 2
lymphocyte 23 20 - 60
esr 60mm/hour 0 – 20mm/hour
RENAL FUNCTION TEST
VALUES NORMAL
SERUM CREATININE 1.2 0.6 – 1.3mg/dl
ELECTROLYTE
Sodium
potassium
Values
133mEq/L
4.1mEq/L
Normal
135 – 147mEq/dl
3.5 -5.2mEq/dl
PROVISIONAL DIAGNOSIS
 COPD
 FEBRILE DELIRUM
OBSERVATION & ORDERS
DAY 1
1.IVF NS 100ML/HOUR
2.DUOLIN NEBULISATION Q6H
3.BUDAMATE NEBULISATION Q12H
4.INJ.LACTAGARD 1.5G IV BD
5.T.AZITHRAL 500 0-1-0.
6.T.PANTOP DSR 1-0-0.
7.TIOMIST MDI OD
8.FORACORT 400 INH BD
DAY 2 and DAY 3
 REPEAT 2 TO 8
 9.T.DERIPHYLLIN OD 300MG 0-0-1
 10.T.DEST M 0-0-1
SOAP ANALYSIS
SUBJECTIVE ANALYSIS
 THE PATIENT COMPLIANTS OF FEVER , COUGH
AND MENTAL CONFUSION.
OBJECTIVE ANALYSIS
 INCREASED ESR
 INCREASED RESPIRATION RATE 30BPM
 ELECTROLYTE NA⁺ DECREASED
 ARTERIAL BLOOD GAS RESULT WILL BE
NEGATIVE
 LACTOBACILLUS SHOWED ABG TEST.
ASSESSMENT
 FROM THE SUBJECTIVE AND OBJECTIVE
ANALYSIS IT IS FOUND TO BE A CASE OF
COPD AND FEBRILE DELIRIUM.
PLAN
 1.ivf NS 100ML/HR FOR FLUID REPLENISHMENT.
 2.INJ.LACTAGARD1.5g(cefoperazone+sulbactam) - ANTIBIOTICS
 3. DUOLIN NEBULISATION(Levosalbutamol 50mcg+ipratropium20mcg)
- BRONCHODIALATORS
 4.BUDAMATE NEBULISATION(BUDESONIDE 1 -2MG TWICE DIALY) -
GLUCOCORTICOID STEROIDS.
 5.T.AZITHRAL 500MG(AZITHROMYCIN 500MG) - ANTIBIOTICS
 6.TIOMIST MDI(TIOTROPIUM BROMIDE 9mcg) - ANTICHOLINERGIC
BRONCHODIALATOR
 7.FORACORT 400(FORMOTEROL/budesonide 4OOmcg/6mcg) -
anticholinergic + beta-2 agonist(bronchodialator))
 8.T PANTOP DSR (PANTOPRAZOLE WITH DOMPERIDONE
SUSTAINED RELEASE) - PROTON PUMP INHIBITOR
 9.T DEST M(desloratidine +montelukast)- ANTI
ALLERGIC/LEUKOTRIENE MODIFIER.
 10.T DERIPHYLLIN OD 300(THEOPHYLLIN OD 300MG) -
METHYLXANTHINE
Prescription Analysis
Merits of prescription
 Prescription follows general
guidelines for the treatment of
COPD
Pharmacist’s role
 Patients may be counseled about the importance of disease
, each medication , dose and administration
Patients Counseling Areas
 FORACORT 400MG AND TIOMIST MDI- SHAKE WELL
BEFORE USE
 T.AZITHRAL 500MG – AZITHROMYCIN SHOULD BE
TAKEN 1 HOUR BEFORE FOOD OR 1 HOUR AFTER
FOOD WITH MAINTAIN TIME DISCIPLINE(12PM EVERY
DAY).
 PANTOP DSR – SHOULD BE TAKEN BEFORE FOOD
 ADVICE PATIENT TO AVOID SITUATION WHICH WILL
EXACERBATE THE CONDITION.
 ADVICE THE PATIENT TO CHECKING THE LUNG
FUNCTION PERIODICALLY.
Athulrag

More Related Content

Similar to Athulrag

Mmr presentation anaesth
Mmr presentation anaesthMmr presentation anaesth
Mmr presentation anaesth
AnaestHSNZ
 
RECENT ADVANCES IN MANAGEMENT OF HIE
RECENT ADVANCES IN MANAGEMENT OF HIERECENT ADVANCES IN MANAGEMENT OF HIE
RECENT ADVANCES IN MANAGEMENT OF HIE
Tauhid Iqbali
 
MALARIAL FEVER A CASE PRESENTATION .pptx
MALARIAL FEVER A CASE PRESENTATION .pptxMALARIAL FEVER A CASE PRESENTATION .pptx
MALARIAL FEVER A CASE PRESENTATION .pptx
drsriram2001
 
Discovery and Mechanistic Study of Mycobacterium tuberculosis PafA Inhibitors...
Discovery and Mechanistic Study of Mycobacterium tuberculosis PafA Inhibitors...Discovery and Mechanistic Study of Mycobacterium tuberculosis PafA Inhibitors...
Discovery and Mechanistic Study of Mycobacterium tuberculosis PafA Inhibitors...
Dr.Shuaib Ahmad
 

Similar to Athulrag (20)

Mmr presentation anaesth
Mmr presentation anaesthMmr presentation anaesth
Mmr presentation anaesth
 
ABG5 Series
ABG5  SeriesABG5  Series
ABG5 Series
 
HIE
HIEHIE
HIE
 
BASIC ICU & OT NOTES 2021 (VERSION 3) FINAL.pdf
BASIC ICU & OT NOTES 2021 (VERSION 3) FINAL.pdfBASIC ICU & OT NOTES 2021 (VERSION 3) FINAL.pdf
BASIC ICU & OT NOTES 2021 (VERSION 3) FINAL.pdf
 
DEVELOPMENT AND VALIDATION OF SPECTROSCOPIC AND CHROMATOGRAPHIC METHOD FOR D...
DEVELOPMENT AND VALIDATION OF SPECTROSCOPIC AND CHROMATOGRAPHIC  METHOD FOR D...DEVELOPMENT AND VALIDATION OF SPECTROSCOPIC AND CHROMATOGRAPHIC  METHOD FOR D...
DEVELOPMENT AND VALIDATION OF SPECTROSCOPIC AND CHROMATOGRAPHIC METHOD FOR D...
 
Case study on CABG surgery
Case study on CABG surgeryCase study on CABG surgery
Case study on CABG surgery
 
Monsoon Illnesses affecting Lungs (Part 1 of 2)
Monsoon Illnesses affecting Lungs (Part 1 of 2)Monsoon Illnesses affecting Lungs (Part 1 of 2)
Monsoon Illnesses affecting Lungs (Part 1 of 2)
 
a case study on burn injury / case presentation on burn injury
a case study on burn injury / case presentation on burn injury a case study on burn injury / case presentation on burn injury
a case study on burn injury / case presentation on burn injury
 
Nc3R\'s Meeting
Nc3R\'s MeetingNc3R\'s Meeting
Nc3R\'s Meeting
 
shanil-endo.pptx
shanil-endo.pptxshanil-endo.pptx
shanil-endo.pptx
 
Nitrobenzene Poisoning (A Case Report) Methhemoglobinemia Due to Nitrobenzene...
Nitrobenzene Poisoning (A Case Report) Methhemoglobinemia Due to Nitrobenzene...Nitrobenzene Poisoning (A Case Report) Methhemoglobinemia Due to Nitrobenzene...
Nitrobenzene Poisoning (A Case Report) Methhemoglobinemia Due to Nitrobenzene...
 
BPP.pptx
BPP.pptxBPP.pptx
BPP.pptx
 
SCRUB.pptx
SCRUB.pptxSCRUB.pptx
SCRUB.pptx
 
RECENT ADVANCES IN MANAGEMENT OF HIE
RECENT ADVANCES IN MANAGEMENT OF HIERECENT ADVANCES IN MANAGEMENT OF HIE
RECENT ADVANCES IN MANAGEMENT OF HIE
 
MALARIAL FEVER A CASE PRESENTATION .pptx
MALARIAL FEVER A CASE PRESENTATION .pptxMALARIAL FEVER A CASE PRESENTATION .pptx
MALARIAL FEVER A CASE PRESENTATION .pptx
 
Sri sha case 1
Sri sha case 1Sri sha case 1
Sri sha case 1
 
Effects of silver nanoparticle (Ag NP) on oxidative stress biomarkers in rat
Effects of silver nanoparticle (Ag NP) on oxidative stress biomarkers in ratEffects of silver nanoparticle (Ag NP) on oxidative stress biomarkers in rat
Effects of silver nanoparticle (Ag NP) on oxidative stress biomarkers in rat
 
Poisoning 2.ppt
Poisoning  2.pptPoisoning  2.ppt
Poisoning 2.ppt
 
Discovery and Mechanistic Study of Mycobacterium tuberculosis PafA Inhibitors...
Discovery and Mechanistic Study of Mycobacterium tuberculosis PafA Inhibitors...Discovery and Mechanistic Study of Mycobacterium tuberculosis PafA Inhibitors...
Discovery and Mechanistic Study of Mycobacterium tuberculosis PafA Inhibitors...
 
Respiratory Drugs
Respiratory DrugsRespiratory Drugs
Respiratory Drugs
 

Athulrag

  • 1.
  • 2. PREPARED BY, ATHUL RAG V IST MPHARM DEPT OF PHARMACY PRACTICE JDT ISLAM COLLEGE OF PHARMACY
  • 3. CASE  A 78 YEAR OLD MALE WAS ADMITTED IN HOSPITAL PRESENTING WITH COMPLIANTS OF FEVER(LOW GRADE) , COUGH AND MENTAL CONFUSION OF 1 DAY. IP NO.IQ2015/2676 DEPT; MEDICINE DOA;14/2/2015 DOD;16/2/2015
  • 5. PAST MEDICAL HISTORY  HISTORY OF BPH SURGERY UNDERGONE 2 YEARS BACK.  HISTORY OF COPD  NO HISTORY OF HTN,DM PAST MEDICATION HISTORY  TIOMIST MDI OD  FORACORT 400 BD
  • 6. PRESENT MEDICAL HISTORY  HISTORY OF FEVER , COUGH, AND MENTAL CONFUSION
  • 8. PHYSICAL EXAMINATION  TEMPERATURE DAY 1 TEMP; 99⁰F DAY 2 TEMP;98.6⁰F  BLOOD PRESSURE DAY 1 BP ; 100/70 DAY 2 BP ; 120/80
  • 9. RESPIRATION SYSTEM RESP.SYSTEM VALUES NORMAL RESPIRATION RATE 30BPM 12 TO 24BPM
  • 10. LAB DIAGNOSIS  HAEMATOLOGY VALUES NORMAL HB 12.7g/dl 12- 16g/dl WBC 9,500Cells/cmm 4,300 - 10,800cells/cmm neutrophils 75 45 - 70 Platelet count 3cells/cmm 1- 4 lakhcells/cumm monocyte 02 1 - 2 lymphocyte 23 20 - 60 esr 60mm/hour 0 – 20mm/hour
  • 11. RENAL FUNCTION TEST VALUES NORMAL SERUM CREATININE 1.2 0.6 – 1.3mg/dl ELECTROLYTE Sodium potassium Values 133mEq/L 4.1mEq/L Normal 135 – 147mEq/dl 3.5 -5.2mEq/dl
  • 14. DAY 1 1.IVF NS 100ML/HOUR 2.DUOLIN NEBULISATION Q6H 3.BUDAMATE NEBULISATION Q12H 4.INJ.LACTAGARD 1.5G IV BD 5.T.AZITHRAL 500 0-1-0. 6.T.PANTOP DSR 1-0-0. 7.TIOMIST MDI OD 8.FORACORT 400 INH BD
  • 15. DAY 2 and DAY 3  REPEAT 2 TO 8  9.T.DERIPHYLLIN OD 300MG 0-0-1  10.T.DEST M 0-0-1
  • 17. SUBJECTIVE ANALYSIS  THE PATIENT COMPLIANTS OF FEVER , COUGH AND MENTAL CONFUSION.
  • 18. OBJECTIVE ANALYSIS  INCREASED ESR  INCREASED RESPIRATION RATE 30BPM  ELECTROLYTE NA⁺ DECREASED  ARTERIAL BLOOD GAS RESULT WILL BE NEGATIVE  LACTOBACILLUS SHOWED ABG TEST.
  • 19. ASSESSMENT  FROM THE SUBJECTIVE AND OBJECTIVE ANALYSIS IT IS FOUND TO BE A CASE OF COPD AND FEBRILE DELIRIUM.
  • 20. PLAN  1.ivf NS 100ML/HR FOR FLUID REPLENISHMENT.  2.INJ.LACTAGARD1.5g(cefoperazone+sulbactam) - ANTIBIOTICS  3. DUOLIN NEBULISATION(Levosalbutamol 50mcg+ipratropium20mcg) - BRONCHODIALATORS  4.BUDAMATE NEBULISATION(BUDESONIDE 1 -2MG TWICE DIALY) - GLUCOCORTICOID STEROIDS.  5.T.AZITHRAL 500MG(AZITHROMYCIN 500MG) - ANTIBIOTICS  6.TIOMIST MDI(TIOTROPIUM BROMIDE 9mcg) - ANTICHOLINERGIC BRONCHODIALATOR  7.FORACORT 400(FORMOTEROL/budesonide 4OOmcg/6mcg) - anticholinergic + beta-2 agonist(bronchodialator))  8.T PANTOP DSR (PANTOPRAZOLE WITH DOMPERIDONE SUSTAINED RELEASE) - PROTON PUMP INHIBITOR  9.T DEST M(desloratidine +montelukast)- ANTI ALLERGIC/LEUKOTRIENE MODIFIER.  10.T DERIPHYLLIN OD 300(THEOPHYLLIN OD 300MG) - METHYLXANTHINE
  • 22. Merits of prescription  Prescription follows general guidelines for the treatment of COPD
  • 23. Pharmacist’s role  Patients may be counseled about the importance of disease , each medication , dose and administration
  • 24. Patients Counseling Areas  FORACORT 400MG AND TIOMIST MDI- SHAKE WELL BEFORE USE  T.AZITHRAL 500MG – AZITHROMYCIN SHOULD BE TAKEN 1 HOUR BEFORE FOOD OR 1 HOUR AFTER FOOD WITH MAINTAIN TIME DISCIPLINE(12PM EVERY DAY).  PANTOP DSR – SHOULD BE TAKEN BEFORE FOOD  ADVICE PATIENT TO AVOID SITUATION WHICH WILL EXACERBATE THE CONDITION.  ADVICE THE PATIENT TO CHECKING THE LUNG FUNCTION PERIODICALLY.